Arkolith/Insider Trading/ARTV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Jun 29, 2026
Net Buying
Open-Market Buys
$292K
Open-Market Sells
$0
Net Open-Market Flow
$292K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Buy(P)2K$8.98$17K16.8M
Jun 25, 2026Buy(P)31K$8.88$275K16.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000711) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML